Professor of Chemistry, Harvard University
Chairman, Entrepreneurship Ventures, Inc.
Chief Technology Officer, Compuware
CEO and Co-Founder, Endeavor
President and Director, Fred Hutchinson Cancer Research Center
Managing Director, GlobalSmartEnergy
Managing Director, TechStars
Assoc. Dir. Of Mobility Research, Carnegie Mellon Silicon Valley
|
|
Coronado Biosciences, a Seattle-based developer of cancer drugs, has raised $7 million in equity and options, according to a filing with the Securities and Exchange Commission. The company lists RJ Tesi as its CEO, and Lindsay Rosenwald, the founder of Paramount Biosciences, as a member of its board.
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
